FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386347295> ?p ?o ?g. }

• W4386347295 abstract "Fexofenadine hydrochloride (HCl) is a second-generation, nonsedating, histamine H1-receptor antagonist used to manage seasonal allergic rhinitis and chronic idiopathic urticaria. A new oral pediatric suspension of fexofenadine HCl has been developed, with the preservative potassium sorbate replacing parabens. The objective of this phase 1 single-center, open-label, randomized, 2-treatment, full-replicated, 4-period, 2-sequence crossover study in healthy adult volunteers was to assess the bioequivalence of 30 mg of the new oral suspension of fexofenadine HCl (test) versus 30 mg of the marketed pediatric oral suspension of fexofenadine HCl (reference). The replicate design was based on the high intra-individual variability of fexofenadine (>30% on Cmax ). The study comprised 68 randomized and treated volunteers. Plasma concentrations of fexofenadine were similar following the administration of a single dose of each formulation. Cmax , AUClast , AUC, median tmax , and mean t1/2z were similar between administrations of the same fexofenadine formulation and between formulations. A high intra-individual variability was confirmed with both formulations. Bioequivalence of the test and reference fexofenadine HCl formulations was demonstrated as the 90% confidence intervals of the geometric least squares mean ratio for Cmax , AUClast , and AUC of fexofenadine were all within the bioequivalence range of 0.80-1.25. There were no serious adverse events (AEs) or study discontinuations due to treatment-emergent AEs with either fexofenadine HCl formulation. The new paraben-free fexofenadine HCl 30-mg oral suspension and marketed fexofenadine HCl 30-mg pediatric oral suspension are bioequivalent under fasting conditions, with no safety concerns and a safety profile consistent with the known profile of fexofenadine." @default.
• W4386347295 created "2023-09-02" @default.
• W4386347295 creator A5036656027 @default.
• W4386347295 creator A5041981997 @default.
• W4386347295 creator A5064874700 @default.
• W4386347295 creator A5092727786 @default.
• W4386347295 date "2023-09-01" @default.
• W4386347295 modified "2023-09-30" @default.
• W4386347295 title "Bioequivalence of 2 Pediatric Formulations of Fexofenadine Hydrochloride Oral Suspension" @default.
• W4386347295 cites W1871553254 @default.
• W4386347295 cites W1965474331 @default.
• W4386347295 cites W1975734854 @default.
• W4386347295 cites W1980421164 @default.
• W4386347295 cites W2002385669 @default.
• W4386347295 cites W200466910 @default.
• W4386347295 cites W2016700982 @default.
• W4386347295 cites W2019773157 @default.
• W4386347295 cites W2025418172 @default.
• W4386347295 cites W2025928937 @default.
• W4386347295 cites W2027206303 @default.
• W4386347295 cites W2040356093 @default.
• W4386347295 cites W2046142879 @default.
• W4386347295 cites W2051163942 @default.
• W4386347295 cites W2052686484 @default.
• W4386347295 cites W2070243063 @default.
• W4386347295 cites W2072883273 @default.
• W4386347295 cites W2073532278 @default.
• W4386347295 cites W2107428567 @default.
• W4386347295 cites W2113798894 @default.
• W4386347295 cites W2146185088 @default.
• W4386347295 cites W2154399286 @default.
• W4386347295 cites W2157060791 @default.
• W4386347295 cites W2171654601 @default.
• W4386347295 cites W2238064848 @default.
• W4386347295 cites W2284640127 @default.
• W4386347295 cites W2317702906 @default.
• W4386347295 cites W2563046258 @default.
• W4386347295 cites W2578315465 @default.
• W4386347295 cites W2802013164 @default.
• W4386347295 cites W2810759571 @default.
• W4386347295 cites W2884081107 @default.
• W4386347295 cites W2914465837 @default.
• W4386347295 cites W2915084183 @default.
• W4386347295 cites W2921179159 @default.
• W4386347295 cites W2989772907 @default.
• W4386347295 cites W2991397591 @default.
• W4386347295 cites W2996681046 @default.
• W4386347295 cites W3005539395 @default.
• W4386347295 cites W3097774983 @default.
• W4386347295 cites W3103337719 @default.
• W4386347295 cites W3129332132 @default.
• W4386347295 cites W3152930070 @default.
• W4386347295 cites W3154319338 @default.
• W4386347295 cites W3170638465 @default.
• W4386347295 cites W4205694130 @default.
• W4386347295 doi "https://doi.org/10.1002/cpdd.1311" @default.
• W4386347295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37655364" @default.
• W4386347295 hasPublicationYear "2023" @default.
• W4386347295 type Work @default.
• W4386347295 citedByCount "0" @default.
• W4386347295 crossrefType "journal-article" @default.
• W4386347295 hasAuthorship W4386347295A5036656027 @default.
• W4386347295 hasAuthorship W4386347295A5041981997 @default.
• W4386347295 hasAuthorship W4386347295A5064874700 @default.
• W4386347295 hasAuthorship W4386347295A5092727786 @default.
• W4386347295 hasBestOaLocation W43863472951 @default.
• W4386347295 hasConcept C112705442 @default.
• W4386347295 hasConcept C142724271 @default.
• W4386347295 hasConcept C204787440 @default.
• W4386347295 hasConcept C22979827 @default.
• W4386347295 hasConcept C27081682 @default.
• W4386347295 hasConcept C2776711289 @default.
• W4386347295 hasConcept C2777056448 @default.
• W4386347295 hasConcept C42404028 @default.
• W4386347295 hasConcept C71924100 @default.
• W4386347295 hasConcept C87813604 @default.
• W4386347295 hasConcept C98274493 @default.
• W4386347295 hasConceptScore W4386347295C112705442 @default.
• W4386347295 hasConceptScore W4386347295C142724271 @default.
• W4386347295 hasConceptScore W4386347295C204787440 @default.
• W4386347295 hasConceptScore W4386347295C22979827 @default.
• W4386347295 hasConceptScore W4386347295C27081682 @default.
• W4386347295 hasConceptScore W4386347295C2776711289 @default.
• W4386347295 hasConceptScore W4386347295C2777056448 @default.
• W4386347295 hasConceptScore W4386347295C42404028 @default.
• W4386347295 hasConceptScore W4386347295C71924100 @default.
• W4386347295 hasConceptScore W4386347295C87813604 @default.
• W4386347295 hasConceptScore W4386347295C98274493 @default.
• W4386347295 hasLocation W43863472951 @default.
• W4386347295 hasLocation W43863472952 @default.
• W4386347295 hasOpenAccess W4386347295 @default.
• W4386347295 hasPrimaryLocation W43863472951 @default.
• W4386347295 hasRelatedWork W2018313535 @default.
• W4386347295 hasRelatedWork W2033685750 @default.
• W4386347295 hasRelatedWork W2053536280 @default.
• W4386347295 hasRelatedWork W2055974197 @default.
• W4386347295 hasRelatedWork W2056422086 @default.
• W4386347295 hasRelatedWork W2312656931 @default.
• W4386347295 hasRelatedWork W2349338867 @default.
• W4386347295 hasRelatedWork W2385472588 @default.

• next